Transcription of GUIDELINES ON STABILITY EVALUATION OF …
{{id}} {{{paragraph}}}
WHO/ - Final ENGLISH ONLY GUIDELINES ON STABILITY EVALUATION OF VACCINES World Health Organization 2006 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: Requests for permission to reproduce or translate WHO publications whether for sale or for noncommercial distribution should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.))
WHO/BS/06.2049-Final Page 3 1. Introduction WHO recommendations and guidelines for production and control of vaccines and other biologicals are scientific and advisory in nature and provide guidance for national regulatory
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
A Stability Testing Guidelines:, STABILITY TESTING, Q1A(R2) Guideline Stability Testing of New, Stability testing Guidelines, Stability Testing of Pharmaceutical, Stability testing of pharmaceutical products, Guidelines, Stability testing of active pharmaceutical, Stability, BRACKETING AND MATRIXING DESIGNS FOR, BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING, GUIDELINES ON STABILITY TESTING OF COSMETIC, GUIDELINES ON STABILITY TESTING OF COSMETIC PRODUCTS, Stability Testing of new Drug, STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS, PHARMACEUTICAL, PHARMACEUTICAL INGREDIENTS AND, FINISHED PHARMACEUTICAL PRODUCTS